Skip to main content
Back to Deerfield

Deerfield's Biopharma Portfolio

Browse 13 Biopharma companies funded by Deerfield. See funding amounts, founder contacts, and investment details.

Biopharma Companies
13
Total Funding in Biopharma
$1.3B

Biopharma Portfolio Companies (13)

Export
BiopharmaHealth CareMedicalPharmaceutical

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

San Diego, United States
September 2025
$100.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalPrecision MedicineTherapeutics

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

San Francisco, United States
June 2024
$20.0M
Series C

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Dublin, Ireland
April 2026
$117.5M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Aurion Biotechnologies is a clinical-stage biotech company.

Seattle, United States
April 2022
$120.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Lomond Therapeutics creates pharmacological platforms that target escape mutations.

San Diego, United States
March 2025
$20.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth Diagnostics

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

San Diego, United States
December 2024
$25.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaTherapeutics

BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.

Palo Alto, United States
May 2024
$200.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

Cambridge, United States
January 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

South San Francisco, United States
January 2023
$78.0M
Series B

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Lausanne, Switzerland
October 2025
$60.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaHealth CarePharmaceuticalTherapeutics

Blade Therapeutics is a discovery stage drug development company.

South San Francisco, United States
November 2018
Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Waltham, United States
June 2016
$409.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

Explore Deerfield's Full Portfolio

View all companies funded by Deerfield across every industry and funding stage.

View Full Deerfield Portfolio